Advertisement
Screener

MEDICINOVA, INC. (MNOV) Repayments of Debt

1.3 / 5 stars · 10/40 Roast Me

MEDICINOVA, INC. Repayments of Debt

MEDICINOVA, INC. (MNOV) reported Repayments of Debt of $15.00 million for the 156-month period ending 2013-09-30, per its 10-Q filed 2013-11-07.

Discontinued › Cash Flow › Financing Activities

us-gaap:RepaymentsOfDebt · last filed 2013-11-07

  • MEDICINOVA, INC. repayments of debt for the quarter ending 2013-09-30 was $0.00.
  • MEDICINOVA, INC. repayments of debt for the quarter ending 2013-06-30 was $0.00.
  • MEDICINOVA, INC. repayments of debt for the quarter ending 2013-03-31 was $0.00.
  • MEDICINOVA, INC. repayments of debt for the quarter ending 2012-09-30 was $0.00.
  • MEDICINOVA, INC. repayments of debt for fiscal 2011 was $15.00M.
Period endRepayments of Debt 3 monthRepayments of Debt 6 monthRepayments of Debt 9 monthRepayments of Debt 12 monthRepayments of Debt 129 monthRepayments of Debt 132 monthRepayments of Debt 135 monthRepayments of Debt 138 monthRepayments of Debt 141 monthRepayments of Debt 144 monthRepayments of Debt 147 monthRepayments of Debt 150 monthRepayments of Debt 153 monthRepayments of Debt 156 month
2013-09-30$0.00
derived: 10-Q 156 month − 10-Q 153 month · filed 2013-11-07
$0.00
derived: sum of 2 quarters · filed 2013-11-07
$0.00
derived: sum of 3 quarters · filed 2013-11-07
$15.00M
10-Q · filed 2013-11-07
2013-06-30$0.00
derived: 10-Q 153 month − 10-Q 150 month · filed 2013-08-08
$0.00
derived: sum of 2 quarters · filed 2013-08-08
$15.00M
10-Q · filed 2013-08-08
2013-03-31$0.00
derived: 10-Q 150 month − 10-K 147 month · filed 2013-05-08
$15.00M
10-Q · filed 2013-05-08
2012-12-31$15.00M
10-K · filed 2013-03-28
2012-09-30$0.00
derived: 10-Q 144 month − 10-Q 141 month · filed 2012-11-08
$0.00
derived: sum of 2 quarters · filed 2012-11-08
$0.00
derived: sum of 3 quarters · filed 2012-11-08
$0.00
derived: sum of 4 quarters · filed 2013-03-28
$15.00M
10-Q · filed 2012-11-08
2012-06-30$0.00
derived: 10-Q 141 month − 10-Q 138 month · filed 2012-08-09
$0.00
derived: sum of 2 quarters · filed 2012-08-09
$0.00
derived: sum of 3 quarters · filed 2013-03-28
$0.00
derived: sum of 4 quarters · filed 2013-03-28
$15.00M
10-Q · filed 2012-08-09
2012-03-31$0.00
derived: 10-Q 138 month − 10-K 135 month · filed 2012-05-10
$0.00
derived: sum of 2 quarters · filed 2013-03-28
$0.00
derived: sum of 3 quarters · filed 2013-03-28
$15.00M
10-Q · filed 2012-05-10
2011-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28
$0.00
derived: sum of 2 quarters · filed 2013-03-28
$15.00M
10-K · filed 2013-03-28
$15.00M
10-K · filed 2012-03-29
2011-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08
$15.00M
10-Q · filed 2012-11-08
$15.00M
10-Q · filed 2011-11-14
2011-06-30$15.00M
10-Q · filed 2012-08-09
$15.00M
10-Q · filed 2011-08-15
2010-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
$0.00
10-Q · filed 2011-11-14
2010-06-30$0.00
10-Q · filed 2011-08-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31
IMMUNIC, INC. (IMUX)United States$0.127B-1.88
Unicycive Therapeutics, Inc. (UNCY)United States$0.134B-3.70
TuHURA Biosciences, Inc./NV (HURA)United States$0.134B-4.88
INOVIO PHARMACEUTICALS, INC. (INO)United States$0.125B-1.35
Curanex Pharmaceuticals Inc (CURX)United States$0.138B
Aardvark Therapeutics, Inc. (AARD)United States$0.121B-1.80
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
Atrium Therapeutics, Inc. (RNA)United States$0.140B